Quest details plans for 250,000 sq. ft. ‘flagship’ lab project in Clifton

Quest Diagnostics has taken the wraps off its plans at the ON3 campus in Nutley and Clifton, where it will build a 250,000-square-foot flagship laboratory facility that will become the largest in its portfolio.

Murphy details plans to revamp Grow New Jersey, ERG programs

Amid his sweeping plan to spur a new wave of innovation in the state’s economy, Gov. Phil Murphy has offered a glimpse at what could come of the incentive programs that have helped bolster New Jersey’s commercial real estate market in recent years.

NKF: New Jersey office leasing hits two-year high for absorption

New Jersey’s office market is riding high from a series of blockbuster leases over the summer, recording its highest quarterly increase in net absorption in two years.

Prism completes site plan, eyes start of construction for Woodbridge rental project

Prism Capital Partners is poised to move forward with its redevelopment of five acres in downtown Woodbridge, where it’s planning a mixed-use project with more than 230 apartments.

Prism unveils plans for Ralph Lauren building in Nutley

Prism Capital Partners has detailed its plans for the Nutley office building that will become home to Ralph Lauren Corp., the latest tenant to commit to its 116-acre ON3 campus.

Incentive program enters final year, drawing concern from CRE sector

With the Grow New Jersey program set to expire in less than a year, the prospect of losing the incentive is already weighing heavily on the state’s commercial real estate market.

Roadway, utility upgrades underway at Prism’s ON3 campus

Prism Capital Partners has launched nearly $10 million in roadway and utility upgrades at the former Hoffmann-LaRoche campus in Nutley and Clifton, as it prepares to welcome new tenants to the 116-acre redevelopment site.

Forward-thinking suburbs ripe for growth

I am convinced more than ever that forward-thinking New Jersey suburbs are poised for a comeback. Many city residents, especially those in their 20s and 60s will seek alternate residences. Towns that have invested in their infrastructure and assets for the long term and are ready to accommodate this exodus of consumers and their preferences will be able to compete for this wealth of talent and the resources they bring to the community.

High hopes for life sciences

For all the time we’ve spent highlighting New Jersey’s glut of sprawling, vacant corporate campuses, it’s easy to lose sight of just how many of them have been rescued in recent years by some of the state’s boldest and most inventive developers. Those success stories are worth telling, which is why we often do at Real Estate NJ. But there are underlying trends or nuances in some of those projects that don’t get as much attention on a day-to-day basis. Like how a crop of innovative, lesser-known biotech and pharmaceutical firms are backfilling space at the former research campuses of Sanofi and Hoffmann-LaRoche, helping to stabilize those sites as their new owners pursue larger redevelopment plans.

CBRE: Growth of pharma, biotech firms offers bright future for R&D space in N.J.

Despite years of consolidation by Big Pharma, New Jersey is one of a handful of markets that stand to gain from a promising growth trajectory for the U.S. life sciences sector.